| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |